Guardant Health CCO Sells $61K in Shares for Tax Withholding
Guardant Health, Inc.
Subscribe to track GH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Guardant Health CCO Sells $61K for Tax Withholding
Company: Guardant Health, Inc. (GH) Form: 4 | Filed: 2025-12-17 Significance: Low
Insider: Freeman Chris Title: Chief Commercial Officer | Relationship: Officer
Transaction: • Type: Tax Withholding Sale • Shares: 594 • Price: $102.67 • Value: $60,986 • Owned After: 26,795
Key Insight: This is a routine, non-discretionary sale to cover tax obligations from 1,402 vesting Restricted Stock Units (RSUs). It does not reflect a change in insider sentiment.
Market Context: The transaction value represents a negligible ~0.0005% of the company's $12.26B market capitalization.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Guardant Health, Inc. (GH)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chief Commercial Officer executed a routine, non-discretionary "sell-to-cover" transaction valued at approximately $61k to satisfy tax obligations on vesting Restricted Stock Units (RSUs).
- Market Impact: Neutral. The transaction is automatic and financially immaterial relative to the company's market capitalization.
Company Information
| Field | Value |
|---|---|
| Company | Guardant Health, Inc. |
| Ticker Symbol | GH |
| CIK | 0001576280 |
| Industry | SERVICES-MEDICAL LABORATORIES |
Insider Information
| Field | Value |
|---|---|
| Name | Freeman Chris |
| CIK | 0001871615 |
| Title/Position | Chief Commercial Officer |
| Relationship | Officer |
Transaction Details
This filing reports the vesting of 1,402 RSUs (Code 'M') and a subsequent automatic sale to cover taxes (Code 'F'). The details below pertain to the tax-related sale, as it has a monetary value.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-15 |
| Transaction Code | F (Payment of tax liability by withholding securities) |
| Security Type | Common Stock |
| Shares Involved | 594 |
| Price Per Share | $102.67 |
| Total Value | $60,985.98 |
| Shares Owned After | 26,795 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $60,985.98 |
| % of Market Cap | ~0.0005% |
| Shares Transacted | 594 |
| % of Shares Outstanding | Not Available |
| Post-Transaction Ownership | 26,795 shares |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction value of ~$61k is insignificant compared to Guardant Health's $12.26 billion market capitalization. Such a small transaction has no bearing on the company's valuation or stock price.
- Ownership Concentration: The insider's final holding of 26,795 shares is a result of a net acquisition of 808 shares (1,402 vested minus 594 sold for taxes). The overall change in ownership is minor.
- Transaction Significance: The transaction is classified as low significance. It is an automatic, non-discretionary sale to cover taxes, as indicated by the 'F' transaction code and the accompanying footnote. It does not signal any change in the insider's outlook on the company.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The filing details a pre-scheduled RSU vesting and an automatic tax-related sale. These events are not based on an active investment decision by the insider and are too small to influence the market.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction size is too small to have a noticeable effect on trading volume.
- Sentiment Indicator: Neutral. The market generally understands that "sell-to-cover" transactions are procedural and not indicative of an insider's sentiment.
Additional Context
Transaction Notes
- Special Circumstances: Footnote 1 explicitly states, "These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder..." This confirms the transaction was a non-discretionary sell-to-cover.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
